Clinical Applications of Nanotechnology and AI Integration
暫譯: 奈米技術與人工智慧整合的臨床應用

納米醫學與人工智慧（AI）的融合正在徹底改變醫療保健，提供前所未有的診斷、藥物傳遞和個性化治療的進展。《納米技術與AI整合的臨床應用》深入探討這些變革性領域，揭示尖端創新及其在現實臨床中的影響。

主要特色：
- 解釋納米技術在靶向藥物傳遞、再生醫學和疾病治療中的角色。
- 討論AI驅動模型如何優化診斷、預測疾病進展和個性化療法。
- 提及納米顆粒在生物系統中的挑戰和倫理考量及其長期影響。
- 提供可持續和綠色的納米技術方法，以實現更安全和更有效的醫療應用。

本書由領先專家編輯，為研究人員、臨床醫生、醫療專業人士和行業領袖提供了寶貴的資源，幫助他們利用納米醫學和AI的潛力來改善全球醫療保健。當我們站在新醫療時代的邊緣時，本書提供了導航精準醫療和技術創新的所需見解。

你準備好探索醫療的未來了嗎？深入本書，發現AI和納米技術如何重塑醫療保健的格局！

Catherine Yang, PhD, MD (h.c.)

Vice President of Academic Affairs & Research, Dean, College of Graduate Studies, and Professor of Molecular Pharmacology, Medicinal Chemistry, and Biomedical Sciences

Dr. Catherine F. Yang earned her Master's and PhD in Medicinal Chemistry from Tufts University, followed by postdoctoral training in Molecular Pharmacology, Clinical Biochemistry, and Oncology at Harvard Medical School.

Currently, Dr. Yang is a Professor of Molecular Pharmacology and Clinical Biochemistry in the Department of Basic Science at the College of Medicine and College of Graduate Studies at California Northstate University (CNU). Before joining CNU in 2016, she was a Professor of Biochemistry and Pharmacology at Rowan University, holding faculty appointments at its Cooper Medical School and the Department of Chemistry & Biochemistry. She has also held research and faculty positions at Harvard Medical School, the American Health Foundation, Boston Biomedical Research Institute, Tokyo University of Medicine and Dentistry, the University of Pennsylvania, Zhejiang University, and Zhejiang University of Technology.

With over 25 years of teaching experience, Dr. Yang specializes in medicinal chemistry, molecular pharmacology, and clinical biochemistry. Her research has significantly contributed to understanding tumor progression, developing novel cancer drugs, type 2 diabetes treatments, and allergy vaccines. She has led research teams investigating proteolytic regulatory mechanisms in advanced prostate cancer, lung cancer, and leukemia. Her work on type 2 diabetes metabolic regulation resulted in a patented dual-function diabetes drug, while her immunological research contributed to an allergy vaccine currently in clinical trials.

Dr. Yang has published over 90 research papers and multiple biomedical science books. She holds 10 patents and has secured numerous grants from the NIH, NSF, Research Corporation, New Jersey Health Foundation, and various pharmaceutical industries and health foundations. Dr. Yang has been engaging in AI in Medine & Biomedical research and she is the member of National Science Foundation National Artificial Intelligence Research Resource special interest group. She also serves on review boards for federal, private, and health foundation funding agencies.

Xiaodong Feng, PharmD, PhD., MD (h.c.)

Dr. Feng is a distinguished academic leader, educator, and researcher renowned for his transformative contributions to pharmacy and medical education, biomedical innovation, and community health. As one of the founding architects of California Northstate University (CNU), he has played a pivotal role in shaping its growth from inception into a multi-disciplinary institution with Colleges of Pharmacy, Medicine, Psychology, Dental Medicine, Health Sciences and PhD programs. His visionary leadership has earned accolades for advancing institutional excellence, interprofessional education, and public health initiatives.

Dr. Feng currently serves as Dean of the College of Pharmacy and Senior Vice President at CNU, where he oversees university operations, student services, admissions, and international programs. As a hands-on administrator and scholar, Dr. Feng holds multiple U.S. patents in cancer therapeutics and has edited and authored seminal textbooks on pharmacogenomics, biosimilars, and advanced pharmacology, lauded by Yale Medical School. His research leadership includes securing NIH grants, establishing CNU's first animal research facility, and advancing initiatives in drug discovery and pharmaceutical entrepreneurship.

Dr. Feng received his Ph.D. in Cellular and Molecular Physiology from the Chinese Academy of Medical Sciences and his Doctor of Pharmacy degree from Albany College of Pharmacy and Health Sciences. His integrated training and expertise in cancer education, along with his clinical practice experiences, community service activities, and skills in cancer research, positioned him to effectively deliver high quality patient care and biomedical/pharmaceutical education. He serves as a professor of oncology and pharmacology at the College of Medicine and College of Pharmacy and practiced as an oncology pharmacy specialist.

Brent Luu, PharmD, BCACP

Dr. Brent Luu is currently a Professor at the Betty Irene Moore School of Nursing, UC Davis. He teaches the Pharmacology series courses across multiple programs including the Master of Health Sciences Physician Assistant/Associate (PA) Studies; the Master Entry Program in Nursing (MEPN); and the Doctorate Nurse Practitioner (DNP) degree programs. Dr. Luu earned his Bachelor of Science Degree in Biochemistry from San Francisco State University in 1995. He also earned a Doctor of Pharmacy degree from University of the Pacific School of Pharmacy in 2000. Dr. Luu has co-authored multiple manuscripts and book chapters in various publications. He is also the lead editor of a pharmacology textbook, Advanced Pharmacology for Prescribers, which was released in January 2021.

In addition, he has been a peer reviewer of various journals such as the JAAPA (Journal of the American Academy of Physician Assistants), JNP (Journal for Nurse Practitioners), the Annals of Internal Medicine, and the British Medical Journal (BMJ). Prior to teaching, Dr. Luu was a clinical pharmacist practitioner at various health system. Dr. Luu's focus is on patient care and medication safety. As an educator, he hopes to train students to stay abreast with new application of technologies to optimize therapeutic outcomes while minimizing adverse drug events as well as improving patient and medication safety. His clinical interests include pain management, neurology, and chronic disease management.

楊凱瑩博士，醫學博士（榮譽）

學術事務與研究副校長、研究生院院長、分子藥理學、藥物化學及生物醫學科學教授

楊凱瑩博士於塔夫茨大學獲得藥物化學碩士及博士學位，隨後在哈佛醫學院接受分子藥理學、臨床生物化學及腫瘤學的博士後訓練。

目前，楊博士是加州北州大學（CNU）醫學院及研究生院基礎科學系的分子藥理學及臨床生物化學教授。在2016年加入CNU之前，她曾擔任羅文大學的生物化學及藥理學教授，並在其庫珀醫學院及化學與生物化學系擔任教職。她還曾在哈佛醫學院、美國健康基金會、波士頓生物醫學研究所、東京醫科牙科大學、賓夕法尼亞大學、浙江大學及浙江工業大學擔任研究及教職。

擁有超過25年的教學經驗，楊博士專注於藥物化學、分子藥理學及臨床生物化學。她的研究對於理解腫瘤進展、開發新型癌症藥物、2型糖尿病治療及過敏疫苗做出了重要貢獻。她曾領導研究團隊調查晚期前列腺癌、肺癌及白血病中的蛋白水解調控機制。她在2型糖尿病代謝調控方面的研究導致了一種獲得專利的雙功能糖尿病藥物，而她的免疫學研究則促成了一種目前正在臨床試驗中的過敏疫苗。

楊博士已發表超過90篇研究論文及多本生物醫學科學書籍。她擁有10項專利，並獲得來自NIH、NSF、研究公司、新澤西健康基金會及各種製藥行業和健康基金會的多項資助。楊博士一直參與醫學與生物醫學研究中的人工智慧，並且是國家科學基金會國家人工智慧研究資源特別興趣小組的成員。她還擔任聯邦、私人及健康基金會資助機構的審查委員會成員。

馮曉東博士，藥學博士，醫學博士（榮譽）

馮博士是一位傑出的學術領導者、教育者及研究者，以其對藥學及醫學教育、生物醫學創新及社區健康的變革性貢獻而聞名。作為加州北州大學（CNU）的創始成員之一，他在塑造該校從創立到成為一所多學科機構的過程中發揮了關鍵作用，該校擁有藥學、醫學、心理學、牙醫學、健康科學及博士課程。他的遠見卓識的領導使他獲得了推進機構卓越、跨專業教育及公共健康倡議的讚譽。

馮博士目前擔任CNU藥學院院長及高級副校長，負責大學運營、學生服務、招生及國際項目。作為一名實幹的管理者和學者，馮博士在癌症治療方面擁有多項美國專利，並編輯及撰寫了多本由耶魯醫學院讚譽的藥物基因組學、生物相似藥物及先進藥理學的教科書。他的研究領導包括獲得NIH資助、建立CNU的第一個動物研究設施，以及推進藥物發現及製藥創業的倡議。

馮博士在中國醫學科學院獲得細胞與分子生理學博士學位，並在太平洋大學藥學院獲得藥學博士學位。他在癌症教育方面的綜合訓練及專業知識，加上他的臨床實踐經驗、社區服務活動及癌症研究技能，使他能夠有效提供高品質的病人護理及生物醫學/藥學教育。他在醫學院及藥學院擔任腫瘤學及藥理學教授，並擔任腫瘤藥學專家。

盧布倫博士，藥學博士，BCACP

盧布倫博士目前是加州大學戴維斯分校貝蒂·艾琳·摩爾護理學院的教授。他教授多個課程的藥理學系列課程，包括健康科學碩士醫師助理/副醫師研究（PA）學位、護理碩士入學課程（MEPN）及護理執業醫師（DNP）學位課程。盧博士於1995年在舊金山州立大學獲得生物化學學士學位，並於2000年在太平洋大學藥學院獲得藥學博士學位。盧博士已共同撰寫多篇手稿及書籍章節，並擔任藥理學教科書《處方者的先進藥理學》的主編，該書於2021年1月發行。

此外，他還擔任多個期刊的同行評審，如JAAPA（美國醫師助理學會期刊）、JNP（護理執業醫師期刊）、內科醫學年鑑及英國醫學期刊（BMJ）。在教學之前，盧博士曾在多個健康系統擔任臨床藥師。盧博士專注於病人護理及用藥安全。作為一名教育者，他希望培訓學生跟上新技術的應用，以優化治療結果，同時最小化不良藥物事件，並改善病人及用藥安全。他的臨床興趣包括疼痛管理、神經學及慢性疾病管理。